The Maritime Executive: Maritime News | Marine News
2 days ago · The maritime industry’s leading source for breaking maritime and marine news including shipping news, offshore news, piracy news and more
AMGEN PROVIDES STATEMENT ON MARITIDE PHASE 1 DATA
1 day ago · THOUSAND OAKS, Calif., Nov. 13, 2024 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today issued the following statement on the MariTide (maridebart cafraglutide, formerly AMG 133) Phase 1 data. "As ...
AMGEN PROVIDES STATEMENT ON MARITIDE PHASE 1 DATA
1 day ago · Published. Nov 13, 2024 5:00am EST. THOUSAND OAKS, Calif., Nov. 13, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today issued the following statement on the MariTide (maridebart cafraglutide, formerly ...
Amgen Defends Its Investigational Monthly Weight Loss Injection …
1 day ago · On Tuesday, a Cantor analyst wrote that additional data from Amgen’s experimental weight loss injection, MariTide, suggests a new potential safety risk tied to the drug. On Wednesday, Amgen Inc ...
gCaptain – Maritime News
Discover the latest maritime news, shipping updates, and offshore industry insights at gCaptain. Trusted by mariners and shipping professionals worldwide, gCaptain delivers real-time reports ...
USNI News - Maritime News and Analysis
3 days ago · Every week, USNI News highlights U.S. Navy, Marine and Coast Guard operations around the world. Aviation News on the latest developments in U.S. and international aviation.
Seatrade Maritime News | Global Maritime & Shipping News …
2 days ago · Daily maritime news covering marine, shipping and offshore updates from the global maritime industry. Sign-up for the daily maritime newsletter.
Marine News - The Maritime Executive
The maritime industry’s leading source for breaking maritime and marine news including shipping news, offshore news, piracy news and more
Amgen obesity drug MariTide: four key questions going forward
May 3, 2024 · The injectable drug MariTide, designed to be given monthly, could be a more attractive option than Wegovy and Zepbound, which are both dosed weekly.
Amgen goes all in on injectable obesity treatment MariTide - STAT
May 2, 2024 · The injectable drug, called MariTide, is in a Phase 2 trial for obesity, and Chief Executive Bob Bradway said on an earnings call that “we are very encouraged with the results” from an interim ...